Moreover, a recent review summed up the rational and current status on imaging of non-prostate cancers using PSMA-targeted radiotracers [12] and cited the work of Wernicke et al. [13] that demonstrated PSMA expression in primary ovarian tumours as well as in ovarian carcinoma metastases. This evidence concerns the gene FOLH1 and ovarian neoplasm.